In MVMR accounting for later life adult body size, higher genetically predicted BMI in this window continued to provide evidence of a reduced risk of overall breast cancer and most subtypes, with HER2-enriched disease remaining the exception. This evidence concerns the gene ERBB2 and breast carcinoma.